莨菪鹼的全球市場:產業分析,市場規模,佔有率,成長,趨勢,及預測(2022年~2028年)
市場調查報告書
商品編碼
1059706

莨菪鹼的全球市場:產業分析,市場規模,佔有率,成長,趨勢,及預測(2022年~2028年)

Global Scopolamine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028

出版日期: | 出版商: Value Market Research | 英文 112 Pages | 商品交期: 最快1-2個工作天內

價格

全球莨菪鹼的市場規模,在預測期間內預計大幅成長。

本報告提供全球莨菪鹼市場調查,市場概要,市場規模和預測,趨勢,成長要素及阻礙因素,各劑型、各流通管道、各地區等分析,再加上企業簡介等資訊。

目錄

第1章 序文

第2章 摘要整理

第3章 莨菪鹼:產業分析

  • 簡介
  • 莨菪鹼市場推動市場要素
  • 莨菪鹼市場阻礙市場要素
  • 莨菪鹼市場機會
  • 莨菪鹼市場趨勢
  • 莨菪鹼市場波特的五力分析
  • 莨菪鹼市場魅力分析

第4章 價值鏈分析

  • 莨菪鹼價值鏈分析
  • 莨菪鹼原料分析
  • 潛在的買主的清單
  • 行銷流通管道

第5章 COVID-19發生的影響分析

  • 莨菪鹼市場上的COVID-19發生的影響分析
  • COVID-19對生產、進口、出口及需求的影響分析
  • 莨菪鹼市場:前V/S後COVID-19
  • 各情境的2020年COVID-19流行對莨菪鹼市場規模的估計影響
  • COVID-19:莨菪鹼市場微及宏觀因素分析

第6章 各劑型的全球莨菪鹼市場分析

  • 各劑型概要
  • 成果資料(2015年~2018年)
  • 各劑型的全球莨菪鹼市場分析
  • 各地區的錠劑的市場分析
  • 各地區的糖漿的市場分析
  • 各地區的注射的市場分析
  • 各地區的貼片的市場分析
  • 各地區的其他劑型的市場分析

第7章 各流通管道的全球莨菪鹼市場分析

  • 各流通管道概要
  • 成果資料(2015年~2018年)
  • 各流通管道的全球莨菪鹼市場分析
  • 各地區的醫院藥局的市場分析
  • 各地區的零售藥局的市場分析
  • 各地區的線上藥局的市場分析

第8章 各地區的全球莨菪鹼市場分析

  • 地區預測
  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第9章 莨菪鹼企業的競爭情形

  • 莨菪鹼市場競爭
  • 夥伴關係/合作/契約
  • 合併和收購
  • 新產品的銷售
  • 其他的開發

第10章 企業簡介

  • 企業佔有率分析
  • 市場集中度
  • Alchem International
  • Alkaloids of Australia
  • Baxter International Inc.
  • Caleb Pharmaceuticals, Inc.
  • Centroflora-Cms
  • Fine Chemicals Corporation
  • GlaxoSmithKline plc
  • Myungmoon Pharma Co. LTD.
  • Novartis AG
  • Perrigo Company plc
  • Phytex Australia
Product Code: VMR11210617

Value Market Research deeply researched the Global Scopolamine Market to foresee a significant growth in the industry over the upcoming years. The global scopolamine market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global scopolamine market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this scopolamine market.

The next sections of the scopolamine market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America - United States, Canada, and Mexico

Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC

Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below-

By Dosage Form

Tablet

Syrup

Injection

Patch

Others

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Scopolamine Market
  • 2.2. Global Scopolamine Market Snapshot

3 . SCOPOLAMINE - INDUSTRY ANALYSIS

  • 3.1. Introduction
  • 3.2. Market Drivers of Scopolamine Market
  • 3.3. Market Restraints of Scopolamine Market
  • 3.4. Opportunities of Scopolamine Market
  • 3.5. Trends of Scopolamine Market
  • 3.6. Porter's Five Force Analysis of Scopolamine Market
  • 3.7. Scopolamine Market Attractiveness Analysis
    • 3.7.1 Market Attractive Analysis by Dosage Form
    • 3.7.2 Market Attractive Analysis by Distribution Channel
    • 3.7.3 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Scopolamine Value Chain Analysis
  • 4.2. Scopolamine Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Scopolamine Raw Material Manufactures List
    • 4.2.3. Price Trend of Scopolamine Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak on Scopolamine Market
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Scopolamine Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Scopolamine Market Size in 2020, by Scenario
  • 5.5. COVID-19: Micro and Macro Factor Analysis on Scopolamine Market

6 . GLOBAL SCOPOLAMINE MARKET ANALYSIS BY DOSAGE FORM

  • 6.1 Overview by Dosage Form
  • 6.2 Historical Data 2015-2018
  • 6.3 Global Scopolamine Market Analysis by Dosage Form
  • 6.4 Market Analysis of Tablet by Regions
  • 6.6 Market Analysis of Syrup by Regions
  • 6.5 Market Analysis of Injection by Regions
  • 6.7 Market Analysis of Patch by Regions
  • 6.8 Market Analysis of Others by Regions

7 . GLOBAL SCOPOLAMINE MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 7.1 Overview by Distribution Channel
  • 7.2 Historical Data 2015-2018
  • 7.3 Global Scopolamine Market Analysis by Distribution Channel
  • 7.4 Market Analysis of Hospital Pharmacies by Regions
  • 7.5 Market Analysis of Retail Pharmacies by Regions
  • 7.6 Market Analysis of Online Pharmacies by Regions

8 . GLOBAL SCOPOLAMINE MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America
    • 8.3.1. Overview and Historic Data
    • 8.3.2. North America Scopolamine Market Estimate By Market Segment
    • 8.3.3. North America Scopolamine Market Estimate By Country
    • 8.3.4. United State
    • 8.3.5. Canada
    • 8.3.6. Mexico
  • 8.4. Europe
    • 8.4.1. Overview and Historic Data
    • 8.4.2. Europe Scopolamine Market Estimate by Market Segment
    • 8.4.3. Europe Scopolamine Market Estimate by Country
    • 8.4.4. United Kingdom
    • 8.4.5. France
    • 8.4.6. Germany
    • 8.4.7. Italy
    • 8.4.8. Russia
    • 8.4.9. Rest Of Europe
  • 8.5. Asia Pacific
    • 8.5.1. Overview and Historic Data
    • 8.5.2. Asia Pacific Scopolamine Market Estimate by Market Segment
    • 8.5.3. Asia Pacific Scopolamine Market Estimate by Country
    • 8.5.4. China
    • 8.5.5. India
    • 8.5.6. Japan
    • 8.5.7. South Korea
    • 8.5.8. Australia
    • 8.5.9. Rest Of Asia Pacific
  • 8.6. Latin America
    • 8.6.1. Overview and Historic Data
    • 8.6.2. Latin America Scopolamine Market Estimate by Market Segment
    • 8.6.3. Latin America Scopolamine Market Estimate by Country
    • 8.6.4. Brazil
    • 8.6.5. Argentina
    • 8.6.6. Peru
    • 8.6.7. Chile
    • 8.6.8. Rest of Latin America
  • 8.7. Middle East & Africa
    • 8.7.1. Overview and Historic Data
    • 8.7.2. Middle East & Africa Scopolamine Market Estimate by Market Segment
    • 8.7.3. Middle East & Africa Scopolamine Market Estimate by Country
    • 8.7.4. Saudi Arabia
    • 8.7.5. UAE
    • 8.7.6. Israel
    • 8.7.7. South Africa
    • 8.7.8. Rest Of Middle East And Africa

9 . COMPETITIVE LANDSCAPE OF THE SCOPOLAMINE COMPANIES

  • 9.1. Scopolamine Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF SCOPOLAMINE INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Alchem International
    • 10.3.1. Company Overview
    • 10.3.2. Financials
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Alkaloids of Australia
    • 10.4.1. Company Overview
    • 10.4.2. Financials
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Baxter International Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financials
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Caleb Pharmaceuticals, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financials
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Centroflora-Cms
    • 10.7.1. Company Overview
    • 10.7.2. Financials
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Fine Chemicals Corporation
    • 10.8.1. Company Overview
    • 10.8.2. Financials
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. GlaxoSmithKline plc
    • 10.9.1. Company Overview
    • 10.9.2. Financials
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Myungmoon Pharma Co. LTD.
    • 10.10.1. Company Overview
    • 10.10.2. Financials
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Novartis AG
    • 10.11.1. Company Overview
    • 10.11.2. Financials
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Perrigo Company plc
    • 10.12.1. Company Overview
    • 10.12.2. Financials
    • 10.12.3. Products
    • 10.12.4. Recent Developments
  • 10.13. Phytex Australia
    • 10.13.1. Company Overview
    • 10.13.2. Financials
    • 10.13.3. Products
    • 10.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Global Scopolamine Market Snapshot
  • Drivers of The Global Scopolamine Market Impact Analysis
  • Restraints of The Global Scopolamine Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Scopolamine Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Scopolamine Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on Scopolamine Market
  • Global Scopolamine Market Analysis by Dosage Form ( USD MN)
  • Historic Data 2015-2018
  • Global Scopolamine Market Analysis in Tablet by Geography ( USD MN)
  • Global Scopolamine Market Analysis in Syrup by Geography ( USD MN)
  • Global Scopolamine Market Analysis in Injection by Geography ( USD MN)
  • Global Scopolamine Market Analysis in Patch by Geography ( USD MN)
  • Global Scopolamine Market Analysis in Others by Geography ( USD MN)
  • Global Scopolamine Market Analysis by Distribution Channel ( USD MN)
  • Historic Data 2015-2018
  • Global Scopolamine Market Analysis in Hospital Pharmacies by Geography ( USD MN)
  • Global Scopolamine Market Analysis in Retail Pharmacies by Geography ( USD MN)
  • Global Scopolamine Market Analysis in Online Pharmacies by Geography ( USD MN)
  • Global Scopolamine Market by Geography ( USD MN)
  • Historic Data 2015-2018
  • North America Scopolamine Market Analysis by Dosage Form ( USD MN)
  • North America Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • North America Scopolamine Market Estimate by Country ( USD MN)
  • United State Scopolamine Market Analysis by Dosage Form ( USD MN)
  • United State Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Canada Scopolamine Market Analysis by Dosage Form ( USD MN)
  • Canada Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Mexico Scopolamine Market Analysis by Dosage Form ( USD MN)
  • Mexico Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Europe Scopolamine Market Analysis by Dosage Form ( USD MN)
  • Europe Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Europe Scopolamine Market Estimate by Country ( USD MN)
  • United Kingdom Scopolamine Market Analysis by Dosage Form ( USD MN)
  • United Kingdom Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • France Scopolamine Market Analysis by Dosage Form ( USD MN)
  • France Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Germany Scopolamine Market Analysis by Dosage Form ( USD MN)
  • Germany Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Italy Scopolamine Market Analysis by Dosage Form ( USD MN)
  • Italy Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Russia Scopolamine Market Analysis by Dosage Form ( USD MN)
  • Russia Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Spain Scopolamine Market Analysis by Dosage Form ( USD MN)
  • Spain Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Rest of Europe Scopolamine Market Analysis by Dosage Form ( USD MN)
  • Rest of Europe Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Asia Pacific Scopolamine Market Analysis by Dosage Form ( USD MN)
  • Asia Pacific Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Asia Pacific Scopolamine Market Estimate by Country ( USD MN)
  • China Scopolamine Market Analysis by Dosage Form ( USD MN)
  • China Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Japan Scopolamine Market Analysis by Dosage Form ( USD MN)
  • Japan Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • India Scopolamine Market Analysis by Dosage Form ( USD MN)
  • India Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • South Korea Scopolamine Market Analysis by Dosage Form ( USD MN)
  • South Korea Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Australia Scopolamine Market Analysis by Dosage Form ( USD MN)
  • Australia Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Rest of Asia Pacific Scopolamine Market Analysis by Dosage Form ( USD MN)
  • Rest of Asia Pacific Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Latin America Scopolamine Market Analysis by Dosage Form ( USD MN)
  • Latin America Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Latin America Scopolamine Market Estimate by Country ( USD MN)
  • Brazil Scopolamine Market Analysis by Dosage Form ( USD MN)
  • Brazil Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Argentina Scopolamine Market Analysis by Dosage Form ( USD MN)
  • Argentina Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Peru Scopolamine Market Analysis by Dosage Form ( USD MN)
  • Peru Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Chile Scopolamine Market Analysis by Dosage Form ( USD MN)
  • Chile Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Rest of Latin America Scopolamine Market Analysis by Dosage Form ( USD MN)
  • Rest of Latin America Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Middle East & Africa Scopolamine Market Analysis by Dosage Form ( USD MN)
  • Middle East & Africa Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Middle East & Africa Scopolamine Market Estimate by Country ( USD MN)
  • Saudi Arabia Scopolamine Market Analysis by Dosage Form ( USD MN)
  • Saudi Arabia Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • UAE Scopolamine Market Analysis by Dosage Form ( USD MN)
  • UAE Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Israel Scopolamine Market Analysis by Dosage Form ( USD MN)
  • Israel Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • South Africa Scopolamine Market Analysis by Dosage Form ( USD MN)
  • South Africa Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Rest of Middle East and Africa Scopolamine Market Analysis by Dosage Form ( USD MN)
  • Rest of Middle East and Africa Scopolamine Market Estimate by Distribution Channel ( USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Scopolamine Report
  • Market Research Process
  • Market Research Methodology
  • Global Scopolamine Market Size, by Region (2019)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Dosage Form
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Scopolamine Market Analysis by Dosage Form
  • Global Scopolamine Market Analysis in Tablet by Region
  • Global Scopolamine Market Analysis in Syrup by Region
  • Global Scopolamine Market Analysis in Injection by Region
  • Global Scopolamine Market Analysis in Patch by Region
  • Global Scopolamine Market Analysis in Others by Region
  • Global Scopolamine Market Analysis by Distribution Channel
  • Global Scopolamine Market Analysis in Hospital Pharmacies by Region
  • Global Scopolamine Market Analysis in Retail Pharmacies by Region
  • Global Scopolamine Market Analysis in Online Pharmacies by Region
  • Global Scopolamine Market by Revenue
  • North America Scopolamine Market by Revenue
  • Europe Scopolamine Market by Revenue
  • Asia Pacific Scopolamine Market by Revenue
  • Latin America Scopolamine Market by Revenue
  • Middle East & Africa Scopolamine Market by Revenue
  • Recent Development in Scopolamine Industry
  • Company Market Share Analysis, 2019
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.